Valuation ICON Public Limited Company

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 20/05/2026 BST			5-day change	1st Jan Change
115.09 ^USD	+1.36%		-1.95%	-36.84%

05-18	Icon Set to Benefit From Rising Clinical Trial Activity, Strong Relationships With Large Pharma, RBC Says	MT
05-13	Icon expands US early phase research capabilities with new clinic and outpatient centres	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	10,290	25,209	15,860	23,304	17,314	8,788	8,788	-
Change	-	144.98%	-37.09%	46.94%	-25.71%	-49.24%	0%	-
Enterprise Value (EV) ¹	9,797	29,891	20,223	26,700	20,201	11,598	11,011	10,280
Change	-	205.12%	-32.34%	32.03%	-24.34%	-42.59%	-5.06%	-6.64%
P/E ratio	31.7x	138x	31.7x	38.3x	22x	18.4x	18.2x	15.4x
PBR	5.56x	3.13x	1.87x	2.53x	1.78x	0.95x	0.87x	0.82x
PEG	-	-2.2x	0x	1.8x	0.8x	-0.5x	17.48x	0.9x
Capitalization / Revenue	3.68x	4.6x	2.05x	2.87x	2.09x	1.09x	1.12x	1.09x
EV / Revenue	3.5x	5.45x	2.61x	3.29x	2.44x	1.44x	1.4x	1.27x
EV / EBITDA	20.6x	30.8x	13.7x	15.8x	11.6x	7.42x	8.08x	7.24x
EV / EBIT	23.9x	45.6x	14.7x	17x	12.6x	8.2x	9.02x	8.28x
EV / FCF	19x	40.6x	48x	26.2x	18.1x	12.9x	13.4x	11.7x
FCF Yield	5.28%	2.46%	2.08%	3.82%	5.54%	7.74%	7.48%	8.57%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	6.15	2.25	6.13	7.4	9.53	6.264	6.329	7.458
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	2,797	5,481	7,741	8,120	8,282	8,031	7,854	8,063
EBITDA ¹	475.7	970	1,479	1,694	1,736	1,562	1,363	1,419
EBIT ¹	409.6	655	1,373	1,568	1,598	1,414	1,220	1,242
Net income ¹	332.3	153.2	505.3	612.3	791.5	533.1	512.7	569.9
Net Debt ¹	-493.6	4,682	4,364	3,396	2,887	2,810	2,223	1,492
Reference price ²	194.98	309.70	194.25	283.07	209.71	115.09	115.09	115.09
Nbr of stocks (in thousands)	52,775	81,398	81,645	82,327	82,559	76,360	76,360	-
Announcement Date	24/02/21	22/02/22	22/02/23	21/02/24	19/02/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ICON PUBLIC LIMITED COMPANY	18.13x	1.43x	7.35x	-.--%	8.67B
LONZA GROUP AG	29.51x	5.23x	16.21x	1.12%	43.14B
BEONE MEDICINES AG	45x	4.51x	28.77x	-.--%	33.02B
REVOLUTION MEDICINES, INC.	-18.56x	281.56x	-16.75x	-.--%	31.32B
IQVIA HOLDINGS INC.	21.08x	2.48x	10.71x	-.--%	28.9B
CELLTRION, INC.	29.22x	7.55x	19.41x	0.42%	25.34B
EUROFINS SCIENTIFIC SE	21.31x	1.87x	8.24x	1.25%	12.5B
IONIS PHARMACEUTICALS, INC.	-20.71x	13.46x	-20.39x	-.--%	12.2B
Average	15.62x	39.76x	6.69x	0.35%	24.39B
Weighted average by Cap.	18.96x	49.49x	9.45x	0.38%